Esophageal squamous cell carcinoma (ESCC), a major histologic type of
esophageal cancer, is one of the frequent causes of
cancer-related death worldwide. Picropodophyllotoxin (PPT) is the main component of
Podophyllum hexandrum root with antitumor activity via apoptosis-mediated mechanisms in several
cancer cells. However, the underlying mechanism of the PPT effects in apoptosis induction in
cancer remains ambiguous. Hence, in this study, we evaluate the anti-
cancer effects of PPT in apoptotic signaling pathway-related mechanisms in ESCC cells. First, to verify the effect of PPT on ESCC cell viability, we employed an MTT assay. PPT inhibited the viability of ESCC cells in time- and dose-dependent manners. PPT induced G2/M phase cell cycle arrest and
annexin V-stained cell apoptosis through the activation of the
c-Jun N-terminal kinase (JNK)/p38 pathways. Furthermore, the treatment of KYSE 30 and KYSE 450 ESCC cells with PPT induced apoptosis involving the regulation of endoplasmic reticulum stress- and apoptosis-related
proteins by
reactive oxygen species (ROS) generation, the loss of mitochondrial membrane potential, and multi-
caspase activation. In conclusion, our results indicate that the apoptotic effect of PPT on ESCC cells has the potential to become a new anti-
cancer drug by increasing ROS levels and inducing the JNK/p38 signaling pathways.